Trial Details
TERMINATEDBasic Information
| Clinical ID | c1912 |
|---|---|
| Identifier | NCT04254549 |
| Trial Title | Rifaximin in Patients With Diabetic Gastroparesis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Diabetic Gastroparesis |
| Interventions | DRUG: Rifaximin|DRUG: Placebo |
Participant Information
| Sponsor | Mayo Clinic |
|---|---|
| City | Jacksonville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2019-06-14 |
|---|---|
| Primary Completion Date | 2025-04-08 |
| Completion Date | 2025-04-11 |